Choose Your News
Loading...
Thumbnail
So far, Boeing and Lockheed have lost only one X-37B launch contract to SpaceX -- but there could be more. [Read More]
Thumbnail
Leaving your retirement to chance is very risky. These moves can improve your future financial security by helping you not run out of money. [Read More]
Thumbnail
The current yield is actually one of the least important variables. [Read More]
Thumbnail
As if we didn't already have poor saving habits, a Republican proposal to alter the treatment of 401(k) contributions could cripple the middle class. [Read More]
Thumbnail
Tesla seems like it has the magic, and it may be sharing it with a chipmaker. Publisher Scholastic, even with some Potter power, does not. [Read More]
Thumbnail
The biggest stories in tech this week didn't disappoint. Here's what you missed. [Read More]
Thumbnail
Get rich slowly with these three promising high-yield dividend payers. [Read More]
Thumbnail
The networking hardware provider is soaring, but too many questions remain. [Read More]
Thumbnail
The video-streaming king has handsomely rewarded its shareholders in recent years, but these three companies could do even better. [Read More]
Should a recent run-up in 2U stock give investors pause? [Read More]
The small education tech company isn't afraid to think long term. [Read More]
Understanding the traits that make 2U unique in the online degree program business. [Read More]
Chegg Inc. stock has enjoyed a phenomenal run this year. We sound a note of caution. [Read More]
A textbook renter turns to more profitable business lines. [Read More]
It's not too late to make a big impact on the money you'll have for retirement. [Read More]
Despite the looming launch of Apple's iPhone X, customers are buying up the new iPhone 8 and 8 Plus in droves. Here's what investors should... [Read More]
Be prepared. The chances might be greater than you think. [Read More]
One of these two stocks looks like a bargain, but it's not the one you should buy. [Read More]
The future of Intercept's liver disease drug hangs in the balance after an FDA warning letter. [Read More]
The Motley Fool provides leading insight and analysis about stocks, helping investors stay informed. [Read More]
Loading...
Motley Fool Popular Tags
3 Stocks - All-Time High Buy Sell - Andrew Anagnost - Apple Inc Stock Hits New High Buy - Apple P2P Payments Aren't - Apple's Iphone X - Better Buy - Beverage Giant Pop - Bill Barrett Corporation Nabors Industries LTD Pioneer - Booz Allen Hamilton - Buying Up - CEO Jeff Immelt - Can Wall Street - Carrols Restaurant Group Paccar Inc - Chances Might - Charter Communications - Cheniere Energy National Beverage - Chinese Provider - Clorox Tractor Supply Company - Coke Pepsi Ambarella - Droves Here - Dynavax Technologies Corporation Adobe Systems - Eog Resources Now Inc - Fda Moves Forward - Fda Warning Letter - First Majestic Pan American Silver - Ford Boardwalk Pipeline Partners - Ford First Solar - Gigafactory Model Y - Home Depot Qualcomm - Inc's Meaningful Gain Today - Intercept's Liver Disease Drug Hangs - Investors Need - Ipo What - Israeli Securities Authority - Leading Insight - Let's Answer - Looming Launch - Los Angeles Which - Minas Gerais Companhia Siderurgica Nacional - Morgan Stanley's Lear - Motley Fool - Natural Resource Partners Alliance Resource Partners - Netflix CEO Reed Hastings - New Iphone 8 - New York Stock Exchange - Newlink Genetics - Norwegian Cruise Lines All - Out Why - Pay Monthly - Pepsico Stock History - Question Once - Retire Early - SS&C Technologies Alarmcom - Social Security - Sony Who - Starwood Hotels - Stay Informed - Then Vestas Wind Systems First Solar - Universal Display Corporation - Universal Studios - Veeva Systems Just Hit - Wayfair Big Lots - Why Intercept Pharmaceuticals - Why Shares -  national Beverage
Preview